Professional News

Most Read

• Today
• Last 7 Days
• Last 30 Days

• 1PRESS RELEASE: 52-Week Study Finds ONGLYZA(TM) (saxagliptin) When Added to Metformin Was Non-Inferior to Titrated Glipizide When Added to Metformin in Reducing Glycosylated Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus
  26 Jun 2010 15:00
• 2Chesnara appoints Tom Howard from Aviva as chief financial officer
  7 Dec 2023 10:58
• 3LifeSafe Holdings signs deals as launches fluid for battery packs
  7 Dec 2023 14:31
• 4IN BRIEF: Novartis welcomes "significant milestone" for Kisqali
  8 Dec 2023 20:08
• 5LONDON BROKER RATINGS: Goldman lifts Landsec and British Land
  5 Dec 2023 10:02

• 1PRESS RELEASE: 52-Week Study Finds ONGLYZA(TM) (saxagliptin) When Added to Metformin Was Non-Inferior to Titrated Glipizide When Added to Metformin in Reducing Glycosylated Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus
  26 Jun 2010 15:00
• 2PipeHawk shares plunge as loss widens on higher costs
  29 Nov 2023 11:53
• 3LONDON BRIEFING: Ashtead in record half-year; tinyBuild cuts outlook
  5 Dec 2023 07:48
• 4LONDON BROKER RATINGS: JPMorgan lifts Smith & Nephew
  3 Nov 2023 09:31
• 5LONDON MARKET CLOSE: FTSE 100 slips as miners hold down index
  4 Dec 2023 16:56

• 1PRESS RELEASE: 52-Week Study Finds ONGLYZA(TM) (saxagliptin) When Added to Metformin Was Non-Inferior to Titrated Glipizide When Added to Metformin in Reducing Glycosylated Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus
  26 Jun 2010 15:00
• 2TRADING UPDATES: Actual Experience appoints administrators
  7 Nov 2023 18:11
• 3TOP NEWS: Halma profit grows, ups dividend as eyes further profit rise
  16 Nov 2023 08:42
• 4LONDON BRIEFING: L&G agrees GBP4.8b buy-in for Boots Pension Scheme
  24 Nov 2023 07:50
• 5LONDON BROKER RATINGS: JPMorgan lifts Smith & Nephew
  3 Nov 2023 09:31